Molecular Formula: C5H7N3
Molecular pondus 109.13
CAS 141-86-6 est medium ad capillos tinctura products.
2,6-diamino-pyrtrin
Diainopyridine
Palestrina, 2,6-diamo-
Pyrrinter, 2,6-Diyliamine
II VI-Diainopyridine XCIX +% &
2,6-Diainopyridine,> XCVIII%
2,6-DAP
2,6-diainminopyridine
2,6, pyridinediamine
VI, amino-II (1h) -pyridinimine
Molecular Formula: C5H7N3
Molecular pondus 109.13
CAS 141-86-6 est medium ad capillos tinctura products.
Structuram:
CAS 141-86-6: Applications, commoda et challenges in modern chemiae
Introductio
CAS 141-86-6, chemica identified as II-aminopyrimidine est heterocyclic organicum compositis cum amplis applications in pharmaceuticals, agrochemicals et materiae scientiae. Et unique structuram, combining a Pyimidine anulum cum amino coetus, grants quod versatility ut aedificium obstructionum in synthetica elit. Hic articulus explorat key utitur, beneficia, et limitations of CAS 141-86-6, quatenus sua significatione per industrias.
CAS 141-86-6 applications
Pharmaceutical synthesis
CAS 141-86-6 est discrimine medium in medicamento progressionem. Serves sicut praecursor antiviralis et anticancer agentibus, inter nucleoside analogs. Exempli gratia eius derivationes sunt incorporatus in pharmaca targeting RNA virus per Mimicking Pyimidine Bases, Disrupting Viral Relationarent.
AGROCHEMICAL formulae
In agricultura, CAS 141-86-6 adhibetur ad synthesize herbicides et fungicides. Eius facultatem ad alligandos enzymes in planta pathogens auget efficacia seges tutela agentibus dum obscuratis environmental perseverantia.
Coordination Chemistry
Et amino et NITROGENIUM-dives structuram de CAS 141-86-6 facit eam a valuable Ligand in metallum, organicum frameworks (MOFS) et Catalysts. Hi materiae usus est in Gas repono, Catalysis et sensoriis.
Biochemical investigationis
Inquisitores utilitas cas 141-86-6 ad studium enzyme inhibition machinationes, praecipue in Kinases et dehydrogenases, adiuvat inventionis of targeted therapies ad metabolicae perturbationes.
CAS 141-86-6 commoda
Structural versatility
In Dual eget coetus CAS 141-86-6 activare diversimode modifications, permittens chemists ad scissor derivationes ad propria applications, ex medicamento candidati ad provecta materiae.
Sumptus-efficens synthesis
Complexus Heterocysples comparari, CAS 141-86-6 potest esse synthesized via directa itineribus, ut condensatio amidines cum β-diketones, reducendo productio costs.
REACTIVITAS
In electronic-dives Pyimidine circulum in cas 141-86-6 facilitates electrophilic substitutione profectae, accelerans synthesim functionalized componit.
Low Environmental Perseverantia
Dissimilis Halogenated Analogs, CAS 141-86-6 Degredes magis in naturali conditionibus, aligning cum viridi Quaestiones principiis.
Limitations de cas 141-86-6
Toxicity de
Longum patefacio ut CAS 141-86-6 ut pose salutem metus, comprehendo respiratoriorum et cutis irritatio, necessitating stricte pertractatio protocols in industriae occasus.
Solubility challenges
In limitata solubility of CAS 141-86-6 in Suspendisse solvents completates eius usum in Aqueous reactiones, saepe requiring organicum solvents qui suscitant salutem et arbitrio de.
Stabilitatem exitibus
Sub acidic aut summus temperatus conditionibus, CAS 141-86-6 potest subire decomposition, restringens suum utilitatem in certa synthetia.
Regulatory crator
Dum Cas 141-86-6 late solebat, evolving ordinationes super Amine, quibus componit potest impulsum suum accessibility in regionibus cum Stringent eget controls.
Futurum expectationes
Innovations in application of CAS 141-86-6 sunt focused in vincit limitations. Nam exempli gratia:
Nanocarrier Systems: Encapsulating CAS 141-86-6 ad augendae solubility et reducere toxicity.
Sustainable synthesis: developing solvente libero vel biocatalytic modi ad producendum cas 141-86-6 cum inferioribus environmental ictum.
Ai-repulsi medicamento Design: Leveraging Cas 141-86-6 scriptor pegmata ad generate novae bioactive moleculis per computational modeling.
Ut praecisione chemicals adolescit, ut CAS 141-86-6 est ad remanere lapidem angularem de industrialis et pharmaceutical elit.